<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-05-24" modified="2020-10-07" version="158">
<accession>Q96IZ0</accession>
<accession>O75796</accession>
<accession>Q6FHY9</accession>
<accession>Q8N700</accession>
<name>PAWR_HUMAN</name>
<protein>
<recommendedName>
<fullName>PRKC apoptosis WT1 regulator protein</fullName>
</recommendedName>
<alternativeName>
<fullName>Prostate apoptosis response 4 protein</fullName>
<shortName>Par-4</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PAWR</name>
<name type="synonym">PAR4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="6945" last="6956">
<title>A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.</title>
<authorList>
<person name="Johnstone R.W."/>
<person name="See R.H."/>
<person name="Sells S.F."/>
<person name="Wang J."/>
<person name="Muthukkumar S."/>
<person name="Englert C."/>
<person name="Haber D.A."/>
<person name="Licht J.D."/>
<person name="Sugrue S.P."/>
<person name="Roberts T."/>
<person name="Rangnekar V.M."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="8943350"/>
<dbReference type="DOI" id="10.1128/mcb.16.12.6945"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH WT1</scope>
</reference>
<reference key="2">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT ARG-78</scope>
</reference>
<reference key="3">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LEU-42; ARG-78; ALA-137 AND ALA-202</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Gene" volume="295" first="109" last="116">
<title>Structural and functional characterization of the upstream regulatory region of the human gene encoding prostate apoptosis response factor-4.</title>
<authorList>
<person name="Hsu S.-C."/>
<person name="Kirschenbaum F."/>
<person name="Miller J."/>
<person name="Cordell B."/>
<person name="McCarthy J.V."/>
</authorList>
<dbReference type="PubMed" id="12242017"/>
<dbReference type="DOI" id="10.1016/s0378-1119(02)00826-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-64</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="7255" last="7263">
<title>Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.</title>
<authorList>
<person name="Chakraborty M."/>
<person name="Qiu S.G."/>
<person name="Vasudevan K.M."/>
<person name="Rangnekar V.M."/>
</authorList>
<dbReference type="PubMed" id="11585763"/>
</citation>
<scope>FUNCTION IN APOPTOSIS AND TUMOR REGRESSION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="FEBS Lett." volume="510" first="57" last="61">
<title>p62 forms a ternary complex with PKCzeta and PAR-4 and antagonizes PAR-4-induced PKCzeta inhibition.</title>
<authorList>
<person name="Chang S."/>
<person name="Kim J.H."/>
<person name="Shin J."/>
</authorList>
<dbReference type="PubMed" id="11755531"/>
<dbReference type="DOI" id="10.1016/s0014-5793(01)03224-0"/>
</citation>
<scope>INTERACTION WITH SQSTM1 AND PRKCZ</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="2432" last="2442">
<title>THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.</title>
<authorList>
<person name="Roussigne M."/>
<person name="Cayrol C."/>
<person name="Clouaire T."/>
<person name="Amalric F."/>
<person name="Girard J.-P."/>
</authorList>
<dbReference type="PubMed" id="12717420"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206271"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH THAP1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="4596" last="4603">
<title>AATF inhibits aberrant production of amyloid beta peptide 1-42 by interacting directly with Par-4.</title>
<authorList>
<person name="Guo Q."/>
<person name="Xie J."/>
</authorList>
<dbReference type="PubMed" id="14627703"/>
<dbReference type="DOI" id="10.1074/jbc.m309811200"/>
</citation>
<scope>INTERACTION WITH AATF</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="13824" last="13832">
<title>PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein.</title>
<authorList>
<person name="Xie J."/>
<person name="Guo Q."/>
</authorList>
<dbReference type="PubMed" id="15671026"/>
<dbReference type="DOI" id="10.1074/jbc.m411933200"/>
</citation>
<scope>INTERACTION WITH BACE1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Mol. Cell" volume="24" first="967" last="976">
<title>Structural basis for protein recognition by B30.2/SPRY domains.</title>
<authorList>
<person name="Woo J.S."/>
<person name="Suh H.Y."/>
<person name="Park S.Y."/>
<person name="Oh B.H."/>
</authorList>
<dbReference type="PubMed" id="17189197"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.11.009"/>
</citation>
<scope>INTERACTION WITH SPSB1 AND SPSB2</scope>
<scope>MUTAGENESIS OF ASN-72</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Exp. Cell Res." volume="283" first="51" last="66">
<title>Apoptosis by Par-4 in cancer and neurodegenerative diseases.</title>
<authorList>
<person name="El-Guendy N."/>
<person name="Rangnekar V.M."/>
</authorList>
<dbReference type="PubMed" id="12565819"/>
<dbReference type="DOI" id="10.1016/s0014-4827(02)00016-2"/>
</citation>
<scope>REVIEW ON FUNCTION IN APOPTOSIS AND NEURODEGENERATIVE DISEASES</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Cell. Biochem." volume="91" first="504" last="512">
<title>Par-4 inducible apoptosis in prostate cancer cells.</title>
<authorList>
<person name="Gurumurthy S."/>
<person name="Rangnekar V.M."/>
</authorList>
<dbReference type="PubMed" id="14755681"/>
<dbReference type="DOI" id="10.1002/jcb.20000"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="20" evidence="1">
<citation type="journal article" date="2010" name="J. Mol. Biol." volume="401" first="389" last="402">
<title>Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4.</title>
<authorList>
<person name="Filippakopoulos P."/>
<person name="Low A."/>
<person name="Sharpe T.D."/>
<person name="Uppenberg J."/>
<person name="Yao S."/>
<person name="Kuang Z."/>
<person name="Savitsky P."/>
<person name="Lewis R.S."/>
<person name="Nicholson S.E."/>
<person name="Norton R.S."/>
<person name="Bullock A.N."/>
</authorList>
<dbReference type="PubMed" id="20561531"/>
<dbReference type="DOI" id="10.1016/j.jmb.2010.06.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 67-74 IN COMPLEX WITH SPSB1</scope>
<scope>INTERACTION WITH SPSB1; SPSB2 AND SPSB4</scope>
<scope>MUTAGENESIS OF ALA-66; GLU-68; LEU-69; ASN-71 AND ASN-72</scope>
<scope>MOTIF</scope>
</reference>
<comment type="function">
<text evidence="8">Pro-apoptotic protein capable of selectively inducing apoptosis in cancer cells, sensitizing the cells to diverse apoptotic stimuli and causing regression of tumors in animal models. Induces apoptosis in certain cancer cells by activation of the Fas prodeath pathway and coparallel inhibition of NF-kappa-B transcriptional activity. Inhibits the transcriptional activation and augments the transcriptional repression mediated by WT1. Down-regulates the anti-apoptotic protein BCL2 via its interaction with WT1. Seems also to be a transcriptional repressor by itself. May be directly involved in regulating the amyloid precursor protein (APP) cleavage activity of BACE1.</text>
</comment>
<comment type="subunit">
<text evidence="5 6 9 10 11 12 13 14 15">Homooligomer. Interacts (via the C-terminal region) with WT1 (PubMed:8943350). Interacts with THAP1 (PubMed:12717420). Interacts with AATF (PubMed:14627703). Interacts with BACE1 (PubMed:15671026). Interacts with SPSB1 (via B30.2/SPRY domain); this interaction is direct and occurs in association with the Elongin BC complex (PubMed:17189197, PubMed:20561531). Interacts with SPSB2 (via B30.2/SPRY domain); this interaction occurs in association with the Elongin BC complex (PubMed:17189197, PubMed:20561531). Interacts with SPSB4 (via B30.2/SPRY domain) (PubMed:20561531); this interaction occurs in association with the Elongin BC complex (PubMed:20561531). Component of a ternary complex composed of SQSTM1 and PRKCZ (PubMed:11755531). Interacts with actin (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-595869">
<id>Q96IZ0</id>
</interactant>
<interactant intactId="EBI-448924">
<id>Q01094</id>
<label>E2F1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-595869">
<id>Q96IZ0</id>
</interactant>
<interactant intactId="EBI-354921">
<id>P11021</id>
<label>HSPA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-595869">
<id>Q96IZ0</id>
</interactant>
<interactant intactId="EBI-2659201">
<id>Q96BD6</id>
<label>SPSB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-595869">
<id>Q96IZ0</id>
</interactant>
<interactant intactId="EBI-353844">
<id>P08670</id>
<label>VIM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-595869">
<id>Q96IZ0</id>
</interactant>
<interactant intactId="EBI-8821912">
<id>Q9D5L7</id>
<label>Spsb1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-595869">
<id>Q96IZ0</id>
</interactant>
<interactant intactId="EBI-8820410">
<id>O88838</id>
<label>Spsb2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-595869">
<id>Q96IZ0</id>
</interactant>
<interactant intactId="EBI-8821982">
<id>Q8R5B6</id>
<label>Spsb4</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text evidence="4">Mainly cytoplasmic in absence of apoptosis signal and in normal cells. Nuclear in most cancer cell lines. Nuclear entry seems to be essential but not sufficient for apoptosis (By similarity). Nuclear localization includes nucleoplasm and PML nuclear bodies.</text>
</comment>
<comment type="tissue specificity">
<text evidence="15">Widely expressed. Expression is elevated in various neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer, Parkinson and Huntington diseases and stroke. Down-regulated in several cancers.</text>
</comment>
<comment type="induction">
<text>By apoptosis.</text>
</comment>
<comment type="domain">
<text evidence="4">The leucine-zipper domain is not essential for apoptosis, but is required for sensitization of cells to exogenous apoptotic insults and for interaction with its partners.</text>
</comment>
<comment type="domain">
<text evidence="4">The SAC domain is a death-inducing domain selective for apoptosis induction in cancer cells. This domain is essential for nuclear entry, Fas activation, inhibition of NF-kappa-B activity and induction of apoptosis in cancer cells (By similarity).</text>
</comment>
<comment type="domain">
<text evidence="14">The B30.2/SPRY domain-binding motif mediates recognition by proteins containing a B30.2/SPRY domain.</text>
</comment>
<comment type="PTM">
<text evidence="4">Preferentially phosphorylated at the Thr-163 by PKC in cancer cells.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PAWRID41641ch12q21.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/pawr/"/>
</comment>
<dbReference type="EMBL" id="U63809">
<property type="protein sequence ID" value="AAC24947.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR536549">
<property type="protein sequence ID" value="CAG38786.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY300794">
<property type="protein sequence ID" value="AAP43693.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007018">
<property type="protein sequence ID" value="AAH07018.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF503628">
<property type="protein sequence ID" value="AAM27453.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31863.1"/>
<dbReference type="RefSeq" id="NP_002574.2">
<property type="nucleotide sequence ID" value="NM_002583.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006719498.1">
<property type="nucleotide sequence ID" value="XM_006719435.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016874866.1">
<property type="nucleotide sequence ID" value="XM_017019377.1"/>
</dbReference>
<dbReference type="PDB" id="2JK9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="B=67-81"/>
</dbReference>
<dbReference type="PDBsum" id="2JK9"/>
<dbReference type="SMR" id="Q96IZ0"/>
<dbReference type="BioGRID" id="111108">
<property type="interactions" value="67"/>
</dbReference>
<dbReference type="CORUM" id="Q96IZ0"/>
<dbReference type="DIP" id="DIP-29003N"/>
<dbReference type="ELM" id="Q96IZ0"/>
<dbReference type="IntAct" id="Q96IZ0">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="MINT" id="Q96IZ0"/>
<dbReference type="STRING" id="9606.ENSP00000328088"/>
<dbReference type="BindingDB" id="Q96IZ0"/>
<dbReference type="iPTMnet" id="Q96IZ0"/>
<dbReference type="PhosphoSitePlus" id="Q96IZ0"/>
<dbReference type="BioMuta" id="PAWR"/>
<dbReference type="DMDM" id="66773935"/>
<dbReference type="EPD" id="Q96IZ0"/>
<dbReference type="jPOST" id="Q96IZ0"/>
<dbReference type="MassIVE" id="Q96IZ0"/>
<dbReference type="MaxQB" id="Q96IZ0"/>
<dbReference type="PaxDb" id="Q96IZ0"/>
<dbReference type="PeptideAtlas" id="Q96IZ0"/>
<dbReference type="PRIDE" id="Q96IZ0"/>
<dbReference type="ProteomicsDB" id="76870"/>
<dbReference type="TopDownProteomics" id="Q96IZ0"/>
<dbReference type="Antibodypedia" id="1824">
<property type="antibodies" value="369 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5074"/>
<dbReference type="Ensembl" id="ENST00000328827">
<property type="protein sequence ID" value="ENSP00000328088"/>
<property type="gene ID" value="ENSG00000177425"/>
</dbReference>
<dbReference type="GeneID" id="5074"/>
<dbReference type="KEGG" id="hsa:5074"/>
<dbReference type="UCSC" id="uc001syx.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5074"/>
<dbReference type="DisGeNET" id="5074"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000177425.10"/>
<dbReference type="GeneCards" id="PAWR"/>
<dbReference type="HGNC" id="HGNC:8614">
<property type="gene designation" value="PAWR"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000177425">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="601936">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96IZ0"/>
<dbReference type="OpenTargets" id="ENSG00000177425"/>
<dbReference type="PharmGKB" id="PA32954"/>
<dbReference type="eggNOG" id="ENOG502QVUF">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000000406"/>
<dbReference type="HOGENOM" id="CLU_076619_0_0_1"/>
<dbReference type="InParanoid" id="Q96IZ0"/>
<dbReference type="OMA" id="MACNDSD"/>
<dbReference type="OrthoDB" id="1363165at2759"/>
<dbReference type="PhylomeDB" id="Q96IZ0"/>
<dbReference type="TreeFam" id="TF332824"/>
<dbReference type="PathwayCommons" id="Q96IZ0"/>
<dbReference type="SIGNOR" id="Q96IZ0"/>
<dbReference type="BioGRID-ORCS" id="5074">
<property type="hits" value="8 hits in 883 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PAWR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q96IZ0"/>
<dbReference type="GeneWiki" id="PAWR"/>
<dbReference type="GenomeRNAi" id="5074"/>
<dbReference type="Pharos" id="Q96IZ0">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96IZ0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="Q96IZ0">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000177425">
<property type="expression patterns" value="Expressed in testis and 225 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q96IZ0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96IZ0">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0015629">
<property type="term" value="C:actin cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043522">
<property type="term" value="F:leucine zipper domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0051017">
<property type="term" value="P:actin filament bundle assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032623">
<property type="term" value="P:interleukin-2 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030889">
<property type="term" value="P:negative regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048147">
<property type="term" value="P:negative regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042130">
<property type="term" value="P:negative regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050860">
<property type="term" value="P:negative regulation of T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042986">
<property type="term" value="P:positive regulation of amyloid precursor protein biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2000774">
<property type="term" value="P:positive regulation of cellular senescence"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901300">
<property type="term" value="P:positive regulation of hydrogen peroxide-mediated programmed cell death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="DisProt" id="DP01603"/>
<dbReference type="IDEAL" id="IID00177"/>
<dbReference type="InterPro" id="IPR026117">
<property type="entry name" value="Par-4"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15093">
<property type="entry name" value="PTHR15093"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="PRKC apoptosis WT1 regulator protein" id="PRO_0000058236">
<location>
<begin position="1"/>
<end position="340"/>
</location>
</feature>
<feature type="region of interest" description="Selective for apoptosis induction in cancer cells (SAC)">
<location>
<begin position="145"/>
<end position="203"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper">
<location>
<begin position="300"/>
<end position="340"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="7">
<location>
<begin position="186"/>
<end position="206"/>
</location>
</feature>
<feature type="short sequence motif" description="B30.2/SPRY domain-binding motif" evidence="14">
<location>
<begin position="68"/>
<end position="72"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="4">
<location>
<begin position="145"/>
<end position="161"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ala-rich">
<location>
<begin position="49"/>
<end position="120"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="108"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKA" evidence="5">
<location>
<position position="163"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8176804." id="VAR_022465" evidence="17">
<original>P</original>
<variation>L</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8176805." id="VAR_022466" evidence="16 17">
<original>P</original>
<variation>R</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8176806." id="VAR_022467" evidence="17">
<original>G</original>
<variation>A</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8176870." id="VAR_022468" evidence="17">
<original>E</original>
<variation>A</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of interaction with SPSB1, SPSB2 and SPSB4." evidence="14">
<original>A</original>
<variation>D</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased interaction with SPSB2. Only slightly increased interaction with SPSB4. Increased interaction with SPSB1, SPSB2 and SPSB4; when associated with A-69." evidence="14">
<original>E</original>
<variation>D</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Only slighlty increased interaction with SPSB2. Only slightly increased interaction with SPSB4. Increased interaction with SPSB1, SPSB2 and SPSB4; when associated with A-68." evidence="14">
<original>L</original>
<variation>I</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with SPSB1, SPSB2 and SPSB4." evidence="14">
<original>N</original>
<variation>A</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with SPSB1-Elongin BC complex and SPSB2 and SPSB4." evidence="13 14">
<original>N</original>
<variation>A</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC24947." ref="1" evidence="18">
<original>AP</original>
<variation>PPAR</variation>
<location>
<begin position="102"/>
<end position="103"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAG38786." ref="2" evidence="18">
<original>I</original>
<variation>M</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC24947." ref="1" evidence="18">
<original>R</original>
<variation>T</variation>
<location>
<position position="281"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JK9"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62627"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q925B0"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11585763"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11755531"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12717420"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14627703"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15671026"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17189197"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20561531"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8943350"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source ref="2"/>
</evidence>
<evidence key="17" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<sequence length="340" mass="36568" checksum="7E7515455402DBF8" modified="2001-12-01" version="1">MATGGYRTSSGLGGSTTDFLEEWKAKREKMRAKQNPPGPAPPGGGSSDAAGKPPAGALGTPAAAAANELNNNLPGGAPAAPAVPGPGGVNCAVGSAMLTRAAPGPRRSEDEPPAASASAAPPPQRDEEEPDGVPEKGKSSGPSARKGKGQIEKRKLREKRRSTGVVNIPAAECLDEYEDDEAGQKERKREDAITQQNTIQNEAVNLLDPGSSYLLQEPPRTVSGRYKSTTSVSEEDVSSRYSRTDRSGFPRYNRDANVSGTLVSSSTLEKKIEDLEKEVVRERQENLRLVRLMQDKEEMIGKLKEEIDLLNRDLDDIEDENEQLKQENKTLLKVVGQLTR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

